AR022646A1 - MOLÉCULA POLINUCLEOTíDICA QUE COMPRENDE UNA SECUENCIA DE STREPTOMYCES AVERMITILES QUE DIRIGE LA RELACIoN DE AVERMICTINAS B2: B1, VECTOR RECOMBINANTE, CÉLULA HUÉSPED, PROCEDIMIENTO PARA OBTENER NUEVA CEPA DE S.AVERMITILIS, CÉLULA DE S.AVERMITILES Y COMPOSICIoN DE CICLOHEXIL B2: CICLOHEXIL B1 AVERMECT - Google Patents
MOLÉCULA POLINUCLEOTíDICA QUE COMPRENDE UNA SECUENCIA DE STREPTOMYCES AVERMITILES QUE DIRIGE LA RELACIoN DE AVERMICTINAS B2: B1, VECTOR RECOMBINANTE, CÉLULA HUÉSPED, PROCEDIMIENTO PARA OBTENER NUEVA CEPA DE S.AVERMITILIS, CÉLULA DE S.AVERMITILES Y COMPOSICIoN DE CICLOHEXIL B2: CICLOHEXIL B1 AVERMECTInfo
- Publication number
- AR022646A1 AR022646A1 ARP000104131A ARP000104131A AR022646A1 AR 022646 A1 AR022646 A1 AR 022646A1 AR P000104131 A ARP000104131 A AR P000104131A AR P000104131 A ARP000104131 A AR P000104131A AR 022646 A1 AR022646 A1 AR 022646A1
- Authority
- AR
- Argentina
- Prior art keywords
- polinucleotydic
- hydroverse
- cecetia
- avermycines
- avermitible
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
- C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14864599P | 1999-08-12 | 1999-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR022646A1 true AR022646A1 (es) | 2002-09-04 |
Family
ID=22526696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000104131A AR022646A1 (es) | 1999-08-12 | 2000-08-10 | MOLÉCULA POLINUCLEOTíDICA QUE COMPRENDE UNA SECUENCIA DE STREPTOMYCES AVERMITILES QUE DIRIGE LA RELACIoN DE AVERMICTINAS B2: B1, VECTOR RECOMBINANTE, CÉLULA HUÉSPED, PROCEDIMIENTO PARA OBTENER NUEVA CEPA DE S.AVERMITILIS, CÉLULA DE S.AVERMITILES Y COMPOSICIoN DE CICLOHEXIL B2: CICLOHEXIL B1 AVERMECT |
Country Status (39)
| Country | Link |
|---|---|
| US (3) | US6632673B1 (es) |
| EP (1) | EP1200606B1 (es) |
| JP (1) | JP3884651B2 (es) |
| KR (1) | KR100489856B1 (es) |
| CN (1) | CN1186446C (es) |
| AP (1) | AP2002002418A0 (es) |
| AR (1) | AR022646A1 (es) |
| AT (1) | ATE341632T1 (es) |
| AU (1) | AU778837B2 (es) |
| BG (1) | BG65902B1 (es) |
| BR (1) | BRPI0013119B8 (es) |
| CA (1) | CA2380872C (es) |
| CO (1) | CO5290295A1 (es) |
| CY (1) | CY1105778T1 (es) |
| CZ (1) | CZ304402B6 (es) |
| DE (1) | DE60031126T2 (es) |
| DK (1) | DK1200606T3 (es) |
| EA (1) | EA200200056A1 (es) |
| ES (1) | ES2272299T3 (es) |
| GT (1) | GT200000136A (es) |
| HK (1) | HK1046710B (es) |
| HR (1) | HRP20020130A2 (es) |
| HU (1) | HU230600B1 (es) |
| IL (2) | IL147563A0 (es) |
| IS (1) | IS6250A (es) |
| MA (1) | MA26813A1 (es) |
| MX (1) | MXPA02001513A (es) |
| NO (1) | NO20020664D0 (es) |
| NZ (1) | NZ516517A (es) |
| OA (1) | OA11998A (es) |
| PA (1) | PA8499501A1 (es) |
| PE (1) | PE20010690A1 (es) |
| PL (1) | PL203818B1 (es) |
| PT (1) | PT1200606E (es) |
| SK (1) | SK288086B6 (es) |
| TN (1) | TNSN00171A1 (es) |
| UY (1) | UY26286A1 (es) |
| WO (1) | WO2001012821A1 (es) |
| ZA (1) | ZA200201072B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3884651B2 (ja) * | 1999-08-12 | 2007-02-21 | ファイザー・プロダクツ・インク | Ｂ２アベルメクチン：ｂ１アベルメクチンの比を指示するストレプトミセス・アベルミティリス遺伝子 |
| RU2293117C2 (ru) * | 2002-02-12 | 2007-02-10 | Пфайзер Продактс Инк. | Ген streptomyces avermitilis и его применение для изменения соотношения авермектинов b2:b1 |
| US7943160B2 (en) * | 2002-05-09 | 2011-05-17 | Scimetrics Limited Corp. | Pest control methods |
| US9493744B2 (en) | 2012-06-20 | 2016-11-15 | Genentech, Inc. | Methods for viral inactivation and other adventitious agents |
| KR102657859B1 (ko) | 2021-04-07 | 2024-04-16 | 윤재식 | 일체형 내화 소켓 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5525506A (en) | 1987-01-23 | 1996-06-11 | Pfizer Inc. | Process for production of avermectins and cultures therefor |
| US5238848A (en) | 1987-01-23 | 1993-08-24 | Pfizer Inc | Cultures for production of avermectins |
| IN167980B (es) * | 1987-01-23 | 1991-01-19 | Pfizer | |
| US5234831A (en) | 1987-01-23 | 1993-08-10 | Pfizer Inc | Cultures for production of B avermectins |
| ES2054822T3 (es) | 1987-10-23 | 1994-08-16 | Pfizer | Procedimiento para la produccion de agliconas de avermectinas y sus cultivos. |
| US5240850A (en) | 1987-10-23 | 1993-08-31 | Pfizer Inc. | Cultures for production of avermectin aglycones |
| DE69023036T2 (de) | 1989-03-31 | 1996-06-13 | Merck & Co Inc | Klonierung von Streptomyces avermitilis Genen zur Biosynthese von Avermectin und Verfahren zu ihrer Verwendung. |
| US5252474A (en) | 1989-03-31 | 1993-10-12 | Merck & Co., Inc. | Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use |
| WO1995004150A1 (en) | 1993-07-30 | 1995-02-09 | Pfizer Inc. | Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| FI942725A (fi) | 1993-12-16 | 1995-06-17 | Pfizer | Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6096548A (en) | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
| EP0964922A4 (en) | 1996-09-27 | 2000-10-25 | Maxygen Inc | METHOD FOR OPTIMIZING GENE THERAPY BY REPEATING SEQUENCE MIXING AND SELECTION |
| EP1007732B1 (en) | 1997-01-17 | 2006-07-26 | Maxygen, Inc. | EVOLUTION OF procaryotic WHOLE CELLS BY RECURSIVE SEQUENCE RECOMBINATION |
| EP1030861A4 (en) | 1997-10-31 | 2001-09-05 | Maxygen Inc | MODIFICATION OF VIRAL TROPISM AND THE DIVERSITY OF HOST SPECIES BY RECOMBINATION OF THE VIRAL GENOME |
| US6248579B1 (en) * | 1998-02-13 | 2001-06-19 | Pfizer Inc | Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| BR9907893A (pt) * | 1998-02-13 | 2000-11-14 | Pfizer Prod Inc | Gene de streptomyces avermitilis que dirige a proporção de avermectinas b2:b1 |
| JP3884651B2 (ja) * | 1999-08-12 | 2007-02-21 | ファイザー・プロダクツ・インク | Ｂ２アベルメクチン：ｂ１アベルメクチンの比を指示するストレプトミセス・アベルミティリス遺伝子 |
-
2000
- 2000-07-24 JP JP2001516908A patent/JP3884651B2/ja not_active Expired - Lifetime
- 2000-07-24 CZ CZ2002-296A patent/CZ304402B6/cs not_active IP Right Cessation
- 2000-07-24 SK SK139-2002A patent/SK288086B6/sk not_active IP Right Cessation
- 2000-07-24 PT PT00944154T patent/PT1200606E/pt unknown
- 2000-07-24 NZ NZ516517A patent/NZ516517A/en unknown
- 2000-07-24 DK DK00944154T patent/DK1200606T3/da active
- 2000-07-24 ES ES00944154T patent/ES2272299T3/es not_active Expired - Lifetime
- 2000-07-24 WO PCT/IB2000/001017 patent/WO2001012821A1/en active Application Filing
- 2000-07-24 AU AU58386/00A patent/AU778837B2/en not_active Expired
- 2000-07-24 CN CNB008117470A patent/CN1186446C/zh not_active Expired - Lifetime
- 2000-07-24 DE DE60031126T patent/DE60031126T2/de not_active Expired - Lifetime
- 2000-07-24 AT AT00944154T patent/ATE341632T1/de active
- 2000-07-24 CA CA002380872A patent/CA2380872C/en not_active Expired - Lifetime
- 2000-07-24 EA EA200200056A patent/EA200200056A1/ru unknown
- 2000-07-24 HU HU0202487A patent/HU230600B1/hu unknown
- 2000-07-24 PL PL353874A patent/PL203818B1/pl unknown
- 2000-07-24 KR KR10-2002-7001807A patent/KR100489856B1/ko active IP Right Grant
- 2000-07-24 BR BRPI0013119A patent/BRPI0013119B8/pt not_active IP Right Cessation
- 2000-07-24 EP EP00944154A patent/EP1200606B1/en not_active Expired - Lifetime
- 2000-07-24 OA OA1200200025A patent/OA11998A/en unknown
- 2000-07-24 AP APAP/P/2002/002418A patent/AP2002002418A0/en unknown
- 2000-07-24 IL IL14756300A patent/IL147563A0/xx unknown
- 2000-07-24 MX MXPA02001513A patent/MXPA02001513A/es active IP Right Grant
- 2000-08-04 CO CO00058605A patent/CO5290295A1/es not_active Application Discontinuation
- 2000-08-10 UY UY26286A patent/UY26286A1/es not_active Application Discontinuation
- 2000-08-10 GT GT200000136A patent/GT200000136A/es unknown
- 2000-08-10 US US09/637,040 patent/US6632673B1/en not_active Expired - Lifetime
- 2000-08-10 PA PA20008499501A patent/PA8499501A1/es unknown
- 2000-08-10 AR ARP000104131A patent/AR022646A1/es active IP Right Grant
- 2000-08-10 PE PE2000000812A patent/PE20010690A1/es not_active Application Discontinuation
- 2000-08-11 TN TNTNSN00171A patent/TNSN00171A1/fr unknown
-
2002
- 2002-01-10 IL IL147563A patent/IL147563A/en active IP Right Grant
- 2002-01-25 IS IS6250A patent/IS6250A/is unknown
- 2002-02-07 MA MA26513A patent/MA26813A1/fr unknown
- 2002-02-07 ZA ZA200201072A patent/ZA200201072B/en unknown
- 2002-02-11 NO NO20020664A patent/NO20020664D0/no not_active Application Discontinuation
- 2002-02-12 HR HR20020130A patent/HRP20020130A2/hr not_active Application Discontinuation
- 2002-03-05 BG BG106479A patent/BG65902B1/bg unknown
- 2002-11-19 HK HK02108367.6A patent/HK1046710B/zh unknown
-
2003
- 2003-06-11 US US10/412,450 patent/US7858340B2/en not_active Expired - Fee Related
- 2003-06-11 US US10/412,444 patent/US20040009560A1/en not_active Abandoned
-
2006
- 2006-11-13 CY CY20061101647T patent/CY1105778T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20032735L (no) | Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse | |
| DK0965578T3 (da) | Hidtil ukendt triglycerik og præparat, som omfatter dette | |
| NO20032733L (no) | Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse | |
| NO20002217L (no) | Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler | |
| NO993003D0 (no) | Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter | |
| NO20012058L (no) | 2-ureido-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler | |
| NO20032187L (no) | Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene | |
| NO991815D0 (no) | Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter | |
| DK1226188T3 (da) | Fremgangsmåde til fremstilling af mannichaddukter, som indeholder polyisobutenphenol | |
| NO20006251D0 (no) | Benzotiepin-1,1-dioksidderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse | |
| NO20020684L (no) | 3(5)-aminopyrazolderivater, fremgangsmåtet for deres fremstilling og deres anvendelse som antitumormidler | |
| TR200100366T2 (tr) | Aktif madde dağıtmaya mahsus bileşikler ve bileşimler. | |
| NO20020687L (no) | 3(5)-ureido-pyrazolderivater, fremgangsmåte for fremstilling av disse og deres anvendelse som antitumormidler | |
| NO20005146L (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
| DK0983995T3 (da) | Dimethyl-(3-aryl-but-3-enyl)-aminforbindelser som farmaceutiske, aktive stoffer | |
| DK0879058T3 (da) | Blandinger hidrørende fra frø af Eugénia Jambolana Lamarck, fremstilling af disse blandinger og visse af deres bestanddele samt anvendelse af disse som lægemidler | |
| NO20022834D0 (no) | Zeolitt SSZ-50, fremgangsmåte for fremstilling og anvendelse av denne | |
| NO20016247L (no) | Streptograminderivater, deres fremstilling samt preparater inneholdende derivatene | |
| NO20022801D0 (no) | Substituerte norbornylaminoderivater, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikumsåvel som medikamenter inneholdende disse | |
| DK1118610T3 (da) | Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne | |
| NO20010219L (no) | Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel | |
| NO974934D0 (no) | 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmåte for deres fremstilling og legemidler som inneholder disse forbindelsene | |
| AR022646A1 (es) | MOLÉCULA POLINUCLEOTíDICA QUE COMPRENDE UNA SECUENCIA DE STREPTOMYCES AVERMITILES QUE DIRIGE LA RELACIoN DE AVERMICTINAS B2: B1, VECTOR RECOMBINANTE, CÉLULA HUÉSPED, PROCEDIMIENTO PARA OBTENER NUEVA CEPA DE S.AVERMITILIS, CÉLULA DE S.AVERMITILES Y COMPOSICIoN DE CICLOHEXIL B2: CICLOHEXIL B1 AVERMECT | |
| FI915492A0 (fi) | 9a-hydroxi-19,11b-oeverbryggade steroider, deras framstaellning och farmaceutiska preparat som innehaoller dem. | |
| DK1053224T3 (da) | Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |